Artiva Biotherapeutics (ARTV) Earnings Date, Estimates & Call Transcripts

$10.49

+0.53 (+5.32%)

(As of 12:06 PM ET)

Upcoming Earnings Date: Dec. 5Estimated
Actual EPS (Aug. 29): -$19.10 Missed By -$18.03
Consensus EPS (Aug. 29): -$1.07

ARTV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARTV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Capital Trends

More Than 30 Federal Agencies Buy From This Cybersecurity Tech

In January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukraine was used to cyberattacks. But the WhisperGate attack just before Russia's full-scale invasion was different. It was larger... and it was aimed at dismantling Ukraine's critical infrastructure. The company's unique expertise and scalable approach allowed them to nearly double revenues between 2021-2023, and they've added another $20 million in new sales orders this year alone. There is no denying - the opportunity here is massive.

Click here to learn how a small company is joining the ranks of Lockheed Martin and Raytheon

Artiva Biotherapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q2 2024	1	($1.59)	($1.59)	($1.59)
Q3 2024	1	($1.00)	($1.00)	($1.00)
Q4 2024	1	($0.59)	($0.59)	($0.59)

ARTV Earnings Date and Information

Artiva Biotherapeutics last issued its quarterly earnings results on August 29th, 2024. The reported ($19.10) earnings per share for the quarter, missing analysts' consensus estimates of ($1.07) by $18.03. Artiva Biotherapeutics has generated $0.00 earnings per share over the last year. Earnings for Artiva Biotherapeutics are expected to grow in the coming year, from ($4.60) to ($2.70) per share. Artiva Biotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 5th, 2024 based off prior year's report dates.

Artiva Biotherapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue	Links
12/5/2024 (Estimated)	-	-	-	-	-	-	-
8/29/2024	Q2 2024	($1.07)	($19.10)	($18.03)	($16.20)	-	-

Artiva Biotherapeutics Earnings - Frequently Asked Questions

When is Artiva Biotherapeutics's earnings date?: Artiva Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 5th, 2024 based off last year's report dates. Learn more on ARTV's earnings history.
Did Artiva Biotherapeutics beat their earnings estimates last quarter?: In the previous quarter, Artiva Biotherapeutics (NASDAQ:ARTV) missed the analysts' consensus estimate of ($1.07) by $18.03 with a reported earnings per share (EPS) of ($19.10). Learn more on analysts' earnings estimate vs. ARTV's actual earnings.
How much revenue does Artiva Biotherapeutics generate each year?: Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded annual revenue of $33.74 million.
What is Artiva Biotherapeutics's EPS forecast for next year?: Artiva Biotherapeutics's earnings are expected to grow from ($4.60) per share to ($2.70) per share in the next year.